Royalty Pharma plc (NASDAQ:RPRX) Q2 2025 Earnings Call Transcript August 6, 2025
Royalty Pharma plc misses on earnings expectations. Reported EPS is $0.05367 EPS, expectations were $1.1.
Operator: Ladies and gentlemen, thank you for standing by. Welcome to Royalty Pharma’s Second Quarter 2025 Earnings Conference Call. I would like now to turn the conference over to George Grofik, Senior Vice President, Head of Investor Relations and Communications. Please go ahead, sir.
George Grofik: Good...
